Research Collaboration with Kansai BNCT Medical Center, Osaka Medical and Pharmaceutical University, Enters Phase 2 — The 1102 Program Toward Aging, Rejuvenation, and Regenerative Medicine
Bloom X³ advances its research collaboration with Kansai BNCT Medical Center to Phase 2. The 1102 Program looks beyond intractable cancers, toward aging, rejuvenation, and regenerative medicine.
